Cassava Sciences Inc vs United States Natural Gas Fund — how do they compare? Cassava Sciences Inc trades at $1.07 (market cap $53.14M), while United States Natural Gas Fund trades at $10.4. Which is the better fit depends on your goals.
| FLNA | UNG | |
|---|---|---|
Market Cap | $53.14M | — |
Sector | Health | Commodities - Energy |
52-Week High | $4.64 | $16.90 |
52-Week Low | $1.09 | $10.15 |
Enterprise Value | -$33.43M | — |
Signals from Pluang's Aura AI — not financial advice
FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.
Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.
The United States Natural Gas Fund (UNG) is currently trading at $10.24, down 2.66% on the day. Technical indicators show a bearish trend with moving averages signaling strong selling pressure, though short-term oscillators like the RSI suggest potential oversold conditions. Recent news highlights natural gas price volatility driven by weather forecasts, LNG export flows, and weekly storage reports. As an exchange-traded fund tracking natural gas futures, UNG's performance is directly tied to commodity price movements rather than company fundamentals.
UNG presents a high-risk, speculative opportunity for investors seeking exposure to natural gas price movements. The fund's structure subjects it to contango-related decay in futures markets, which has historically eroded long-term value. While short-term price movements offer trading opportunities, structural challenges and commodity volatility create significant risks for buy-and-hold investors.
Trailing returns across standard periods
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →UNG is a commodity ETF that tracks the daily price movements of natural gas futures. It primarily invests in front-month contracts at the Henry Hub, making it a highly volatile tool for short-term trading rather than long-term holding due to contango and roll costs.
Read more on UNG →